Skip to main content

Table 1 Age and geographic regions of patients with metastatic colon cancer in the primary analysis (N = 1041)

From: Unsupported off-label chemotherapy in metastatic colon cancer

  N (%)  
  All subjects 1041 Individuals receiving any of the three unsupported off-label therapies 139 (13%) p -value
Age
<50 277 (27) 44 (32) 0.014
50-59 358 (34) 52 (37)
60-69 242 (23) 34 (24)
>70 117 (11) 9 (6)
Unknown 47 (5) 0
Region
Midwest 269 (26) 33 (24) 0.374
Northeast 107 (10) 17 (12)
Southeast 370 (36) 41 (29)
Southwest 126 (12) 21 (15)
West 96 (9) 17 (12)
Unknown 72 (7) 10 (7)